Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Medipost
DescriptionConsists of allogeneic mesenchymal stem cells from umbilical cord blood
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase I/II
Standard IndicationGraft-versus-host disease (GvHD)
Indication DetailsTreat graft-versus-host disease (GvHD) associated with hematopoietic stem cell transplantation
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today